Pharming Group NV - ADRPHAR
13F holders, Q4 2024 (December 31)5holders +1
2new positions
1sold out
$10.06avg. 13F price*
At the end of Q4 2024, 5 institutions reported holding Pharming Group NV - ADR (PHAR) in their 13F filings, up 1 from Q3 2024. 2 opened new positions and 1 sold out. The largest holders were Silverberg Bernstein Capital Management LLC ($483K), Morgan Stanley ($26K) and Osaic Holdings, Inc. ($5K).
- Company
- Pharming Group NV - ADR
- CUSIP
- 71716E105
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2024 → Q4 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 2 | $5K |
| Exits | 1 | $3K |
All 13F filers, Q3 2024 → Q4 2024: 7,380 shares bought and 1,026 shares sold, net +6,354 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| Silverberg Bernstein Capital Management LLC | 0.43% | Add +16.8% | 47,997 | $483K |
| Morgan Stanley | 0.00% | Reduce -21.2% | 2,600 | $26K |
| Osaic Holdings, Inc. | 0.00% | New | 483 | $5K |
| Farther Finance Advisors, LLC | 0.00% | No change | 11 | $111 |
| UBS Group AG | 0.00% | New | 10 | $101 |
"% of holder's portfolio" is PHAR's weight in each manager's 13F, not the share of Pharming Group NV - ADR the manager owns.